Atlas Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$692K Sell
2,829
-123
-4% -$28.6K 0.71% 26
2025
Q4
$611K Sell
2,952
-50
-2% -$9.89K 0.67% 27
2025
Q3
$557K Sell
3,002
-125
-4% -$21.4K 0.57% 28
2025
Q2
$478K Sell
3,127
-425
-12% -$65.3K 0.55% 26
2025
Q1
$589K Sell
3,552
-370
-9% -$57.9K 0.73% 21
2024
Q4
$567K Sell
3,922
-150
-4% -$23.2K 0.72% 21
2024
Q3
$660K Buy
+4,072
New +$649K 1.01% 18
2023
Q3
Sell
-4,944
Closed -$841K 23
2023
Q2
$841K Buy
+4,944
New +$798K 2.42% 11

Other funds holding JNJ

Atlas Wealth Partners's JNJ Position: Q1 2026 in Review

Atlas Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 4.2% in Q1 2026, selling an estimated $28.6K and leaving 2,829 shares worth $692K. The position accounts for 0.71% of the portfolio, ranked #26.

Atlas Wealth Partners first reported a position in JNJ in Q2 2023 and has held it in 8 quarters since. The position peaked at $841K in Q2 2023. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Atlas Wealth Partners held 2,829 shares of Johnson & Johnson worth $692K as of Q1 2026.
  • Atlas Wealth Partners sold 123 Johnson & Johnson shares in Q1 2026, an estimated $28.6K.
  • Johnson & Johnson made up 0.71% of Atlas Wealth Partners's portfolio in Q1 2026, its #26 holding.
  • Atlas Wealth Partners first reported a position in Johnson & Johnson in Q2 2023 and has held it in 8 quarters since.
  • Atlas Wealth Partners's Johnson & Johnson position peaked at $841K in Q2 2023.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Atlas Wealth Partners's 13F filing for Q1 2026, filed 29 Apr 2026.